Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: Two cases

Rimas V. Lukas*, Janani Vigneswaran, Ravi Salgia

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction. Progression of central nervous system (CNS) metastases from small cell lung cancer (SCLC) after radiation therapy is associated with a poor prognosis. Case reports.We present two cases of patients with progressive CNS metastases from SCLC treated with oral temozolomide and etoposide. Sustained clinical responses and radiographic stability were demonstrated. The palliative chemotherapy regimen was well tolerated. Discussion. A regimen of oral temozolomide and etoposide for progressive CNS metastases from SCLC is well tolerated and may be associated with sustained stability of disease.

Original languageEnglish (US)
JournalTumori
Volume99
Issue number2
DOIs
StatePublished - Mar 1 2013

Keywords

  • Central nervous system
  • Etoposide
  • Meningeal carcinomatosis
  • Neoplasm metastasis
  • Small cell lung carcinoma
  • Temozolomide

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: Two cases'. Together they form a unique fingerprint.

Cite this